Literature DB >> 28361768

Structural and functional characterization of nerve fibres in polyneuropathy and healthy subjects.

Páll Karlsson1, Simon Haroutounian2, Michael Polydefkis3, Jens R Nyengaard4, Troels S Jensen5.   

Abstract

OBJECTIVES: Quantification of intraepidermal nerve fibre density (IENFD) is an important small fibre measure in distal symmetric polyneuropathies (DSP), but quantitative evaluation of additional structural and functional factors may help in elucidating the underlying mechanisms, and in improving the diagnostic accuracy in DSP. The literature reports a weak or moderate relationship between IENFD and spontaneous and evoked pain in neuropathies, but the relationship between functional and structural small fibre parameters in patients with DSP is unclear. The objectives of the current study, therefore, were to determine morphological and functional parameters related to small nerve fibres in subjects with distal symmetric polyneuropathy (DSP) and healthy controls, and to characterize the interplay among these parameters in these two groups.
MATERIALS AND METHODS: 17 patients with painful DSP (≥4 on 0-10 numerical rating scale) and with symptoms and signs of small fibre abnormality (with or without large fibre involvement) and 19 healthy control subjects underwent comprehensive functional and structural small fibre assessments that included quantitative sensory testing, response to 30min topical application of 10% capsaicin and analysis of skin biopsy samples taken from the distal leg (IENFD, epidermal and dermal nerve fibre length densities (eNFLD, dNFLD) using global spatial sampling and axonal swelling ratios (swellings/IENFD and swellings/NFLD)).
RESULTS: DSP patients had reduced sensitivity to cold (median -11.07°C vs. -2.60, P≤0.001) and heat (median 46.7 vs. 37.70, P≤0.001), diminished neurovascular (median 184 vs. 278 mean flux on laser Doppler, P=0.0003) and pain response to topical capsaicin (median 10 vs. 35 on 0-100 VAS, P=0.0002), and lower IENFD, eNFLD and dNFLD values combined with increased swelling ratios (all P<0.001) compared to healthy controls. The correlation between structural and functional parameters was poor in DSP patients, compared with healthy controls. In healthy controls eNFLD and dNFLD, IENFD and eNFLD, IENFD and dNFLD all correlated well with each other (r=0.81; P≤0.001, r=0.58; P=0.009, r=0.60; P=0.007, respectively). In DSP, on the other hand, only eNFLD and dNFLD showed significant correlation (r=0.53, P=0.03). A diagnostic approach of combined IENFD and eNFLD utilization increased DSP diagnostic sensitivity from 82.0% to 100% and specificity from 84.0% to 89.5%.
CONCLUSIONS: This study presents a rigorous comparison between functional and morphological parameters, including parameters such as eNFDL and dNFLD that have not been previously evaluated in this context. The correlation pattern between functional and structural small fibre parameters is different in patients with DSP when compared to healthy controls. The findings suggest a more direct relationship between structure and function of nerve fibres in healthy controls compared to DSP. Furthermore, the findings suggest that combining IENFD with measurement of NFLD improves the diagnostic sensitivity and specificity of DSP. IMPLICATIONS: Combining small fibre parameters may improve the diagnostic accuracy of DSP.
Copyright © 2015 Scandinavian Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Global spatial sampling; IENFD; Nerve fibre length density; Polyneuropathy; Skin biopsy

Mesh:

Year:  2015        PMID: 28361768     DOI: 10.1016/j.sjpain.2015.08.007

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  10 in total

1.  The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging.

Authors:  Silvia Lo Vecchio; Hjalte Holm Andersen; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2018-05-29       Impact factor: 1.972

2.  Slow-gamma frequencies are optimally guarded against effects of neurodegenerative diseases and traumatic brain injuries.

Authors:  Pedro D Maia; Ashish Raj; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2019-06-04       Impact factor: 1.621

3.  Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurological diseases.

Authors:  Pedro D Maia; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2017-04-10       Impact factor: 1.621

4.  Characterization of Patients With and Without Painful Peripheral Neuropathy After Receiving Neurotoxic Chemotherapy: Traditional Quantitative Sensory Testing vs C-Fiber and Aδ-Fiber Selective Diode Laser Stimulation.

Authors:  Mikhail I Nemenov; Harutyun Alaverdyan; Carrie Burk; Kristen Roles; Karen Frey; Yan Yan; Gene Kazinets; Simon Haroutounian
Journal:  J Pain       Date:  2021-12-09       Impact factor: 5.383

Review 5.  The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Authors:  Shannon M Smith; Robert H Dworkin; Dennis C Turk; Ralf Baron; Michael Polydefkis; Irene Tracey; David Borsook; Robert R Edwards; Richard E Harris; Tor D Wager; Lars Arendt-Nielsen; Laurie B Burke; Daniel B Carr; Amy Chappell; John T Farrar; Roy Freeman; Ian Gilron; Veeraindar Goli; Juergen Haeussler; Troels Jensen; Nathaniel P Katz; Jeffrey Kent; Ernest A Kopecky; David A Lee; William Maixner; John D Markman; Justin C McArthur; Michael P McDermott; Lav Parvathenani; Srinivasa N Raja; Bob A Rappaport; Andrew S C Rice; Michael C Rowbotham; Jeffrey K Tobias; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2017-02-27       Impact factor: 5.820

Review 6.  Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.

Authors:  Troels S Jensen; Pall Karlsson; Sandra S Gylfadottir; Signe T Andersen; David L Bennett; Hatice Tankisi; Nanna B Finnerup; Astrid J Terkelsen; Karolina Khan; Andreas C Themistocleous; Alexander G Kristensen; Mustapha Itani; Søren H Sindrup; Henning Andersen; Morten Charles; Eva L Feldman; Brian C Callaghan
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

7.  Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial.

Authors:  Karolina S Khan; Kristian Overgaard; Hatice Tankisi; Pall Karlsson; Louise Devantier; Søren Gregersen; Troels S Jensen; Nanna B Finnerup; Rodica Pop-Busui; Ulrik Dalgas; Henning Andersen
Journal:  Diabetologia       Date:  2022-01-19       Impact factor: 10.122

8.  Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study.

Authors:  Alexander Hincker; Karen Frey; Lesley Rao; Nina Wagner-Johnston; Arbi Ben Abdallah; Benjamin Tan; Manik Amin; Tanya Wildes; Rajiv Shah; Pall Karlsson; Kristopher Bakos; Katarzyna Kosicka; Leonid Kagan; Simon Haroutounian
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

9.  Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy.

Authors:  Pall Karlsson; Sandra S Gylfadottir; Alexander G Kristensen; Juan D Ramirez; Pedro Cruz; Nhu Le; Pallai R Shillo; Solomon Tesfaye; Andrew S C Rice; Hatice Tankisi; Nanna B Finnerup; Jens R Nyengaard; Troels S Jensen; David L H Bennett; Andreas C Themistocleous
Journal:  Diabetologia       Date:  2021-01-23       Impact factor: 10.122

10.  Transient hypoalgesia after COVID-19 infection.

Authors:  Juliane Becker; Aikaterini Papagianni; Eva Herrmann; Frank Nöller; Claudia Sommer; Heike L Rittner
Journal:  Pain Rep       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.